| Bioactivity | JMV-1645 is a potent and selective B1 bradykinin receptor antagonist with a Ki value of 0.023 nM on the human cloned B1 receptor. JMV-1645 can be utilized in trauma and infection research[1]. |
| CAS | 284037-77-0 |
| Sequence | H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH |
| Shortening | H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH |
| Formula | C49H69N13O12S |
| Molar Mass | 1064.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bedos P, et al. A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist. J Med Chem. 2000 Jun 15;43(12):2387-94. |
JMV-1645
CAS: 284037-77-0 F: C49H69N13O12S W: 1064.22
JMV-1645 is a potent and selective B1 bradykinin receptor antagonist with a Ki value of 0.023 nM on the human cloned B1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.